$709.59
0.69%
NYSE, Jul 11, 10:00 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Stock price

$709.59
-8.17 1.14% 1M
+124.51 21.28% 6M
+139.68 24.51% YTD
+134.36 23.36% 1Y
+380.78 115.81% 3Y
+564.61 389.44% 5Y
+478.16 206.61% 10Y
+664.38 1,469.54% 20Y
NYSE, Closing price Fri, Jul 11 2025
-4.95 0.69%
ISIN
US58155Q1031
Symbol
MCK
Sector

Key metrics

Basic
Market capitalization
$88.6b
Enterprise Value
$88.6b
Net debt
positive
Cash
$5.7b
Shares outstanding
125.0m
Valuation (TTM | estimate)
P/E
27.1 | 18.8
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.2
EV/FCF
17.0
P/B
negative
Dividends
DPS
$2.75
Yield 1Y | 5Y
0.4% | 0.6%
Growth 1Y | 5Y
14.6% | 11.2%
Payout 1Y | 3Y
10.7% | 9.9%
Increased
12 Years
Financials (TTM | estimate)
Revenue
$359.1b | $410.1b
EBITDA
$5.7b | $6.6b
EBIT
$5.0b | $6.1b
Net Income
$3.3b | $4.7b
Free Cash Flow
$5.2b
Growth (TTM | estimate)
Revenue
16.2% | 14.2%
EBITDA
24.3% | 30.4%
EBIT
28.2% | 38.7%
Net Income
9.8% | 43.2%
Free Cash Flow
44.1%
Margin (TTM | estimate)
Gross
3.6%
EBITDA
1.6% | 1.6%
EBIT
1.4%
Net
0.9% | 1.2%
Free Cash Flow
1.5%
Financial Health
Equity Ratio
-2.8%
Return on Equity
-158.9%
ROCE
37.2%
ROIC
-
Debt/Equity
-2.7
More
EPS
$26.2
FCF per Share
$41.8
Short interest
1.6%
Employees
48k
Rev per Employee
$7.5m
Show more

Is McKesson a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

McKesson Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a McKesson forecast:

17x Buy
81%
4x Hold
19%

Analyst Opinions

21 Analysts have issued a McKesson forecast:

Buy
81%
Hold
19%

Financial data from McKesson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
359,051 359,051
16% 16%
100%
- Direct Costs 346,177 346,177
17% 17%
96%
12,874 12,874
2% 2%
4%
- Selling and Administrative Expenses 7,841 7,841
10% 10%
2%
- Research and Development Expense - -
-
-
5,669 5,669
24% 24%
2%
- Depreciation and Amortization 636 636
0% 0%
0%
EBIT (Operating Income) EBIT 5,033 5,033
28% 28%
1%
Net Profit 3,295 3,295
10% 10%
1%

In millions USD.

Don't miss a Thing! We will send you all news about McKesson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

McKesson Stock News

Neutral
Business Wire
18 days ago
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relat...
Positive
Seeking Alpha
20 days ago
Timing of income is an important consideration. Monthly dividend stocks provide recurring income and faster compounding of wealth. I highlight two monthly dividend payers that are undervalued while supporting well-covered yields. Both carry strong balance sheets with A- and BBB+ credit ratings and durable business models that support growth for years to come.
Positive
Seeking Alpha
23 days ago
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth qua...
More McKesson News

Company Profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Employees 48,000
Founded 1833
Website www.mckesson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today